Company News for April 17, 2012 - Corporate Summary
17 Abril 2012 - 6:06AM
Zacks
• Shares of Dreams Inc. (NYSEAMEX:DRJ) rose
30.3% after the retailer agreed to be purchased by privately owned
online sports merchandiser Fanatics Inc. for $3.45 a share
• Shares of Endocyte Inc. (NASDAQ:ECYT) jumped
100.5% after Merck & Co. (NYSE:MRK) struck a deal worth up to
$1 billion to develop an experimental cancer drug and announced
that it would pay $120 million upfront to Endocyte with additional
payouts of up to $880 million
• Mattel Inc. (NASDAQ:MAT) lost 9.1% after
reporting first quarter earnings per share of $0.06, missing the
Zacks Consensus Estimate of $0.07 by a penny
• Gannett Co. (NYSE:GCI) fell 7.6% a day after
the media firm released its earnings, even though quarterly
earnings per share of $0.34 surpassed the Zacks Consensus Estimate
of $0.31
DREAMS INC (DRJ): Free Stock Analysis Report
ENDOCYTE INC (ECYT): Free Stock Analysis Report
GANNETT INC (GCI): Free Stock Analysis Report
MATTEL INC (MAT): Free Stock Analysis Report
MERCK & CO INC (MRK): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Dreams, Inc. (AMEX:DRJ)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Dreams, Inc. (AMEX:DRJ)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre Dreams, Inc. da American Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Dreams Common Stock